Marion Pouillard - Gilde Healthcare


All team members
Marion Pouillard
The Netherlands

Marion Pouillard


Marion Pouillard joined Gilde Healthcare in 2023 and is investigating both private and publicly traded companies. She is involved in deal sourcing, due diligence and portfolio management.

Prior to joining Gilde Healthcare, Marion worked as an Associate at Kurma Partners – BioFund III, where she participated in the creation of Corteria Pharmaceuticals and Vico Therapeutics, and the closing of IO Biotech, Step Pharma and Lucine. During her time at Kurma she joined the board of Imcheck Therapeutics and Amolyt Pharma.

Marion has a double MSc in Biology from the European Magister of Genetics (France) and Milano-Bicocca University (Italy) and graduated from ESCP Management School with a major in Biopharmaceutical Management.

She is a French citizen based in Gilde’s Utrecht office.

Janke Dittmer

General Partner Healthtech
Janke Dittmer joined Gilde in 2011 as a Partner. He led Gilde’s investment in Definiens (acquired by AZ), Sapiens (acquired by Medtronic), Volta Medical, Big Health, FIRE1, Lumeon and Nyxoah (IPO on NASDAQ) and was...

Oksana van Vliet

Legal & AML/KYC counsel
Oksana van Vliet joined Gilde Healthcare in 2021 as Legal & AML/KYC Counsel. Her primary focus within Gilde Healthcare is to assist with legal, regulatory and compliance related matters. Oksana has over 10 years of...

Paulien Schippers

Senior Controller
Paulien Schippers joined Gilde Healthcare in 2015. Paulien is responsible for the financial administration, the preparation of reports and the management of the administrative organization of the various Gilde Healthcare entities. Prior to joining Gilde,...